CCSA’s Issues of Substance Conference

Oral Presentation B5
Monitoring and Prevention Strategies to Reduce Opioid Related Harms

Date & Time Monday, November 25
2:00 - 3:30

Add to Calendar

B5.1 Prescription Monitoring Programs and Opioid-Related Outcomes 

Mark Asbridge, Dalhousie University
Jill Hayden, Dalhousie University
Maria Wilson, Dalhousie University
Alysia Robinson, Dalhousie University
Emily Rhodes, Dalhousie University
Peter MacDougall, Nova Scotia Prescription Monitoring Program
Samuel Campbell, Charles V. Keating, Emergency and Trauma Centre

B5.2 Multi-sector, Multi-strategy Community Plans to Prevent and Reduce Opioid-related Harms in North America 

Pamela Leece, Public Health Ontario
Triti Khorasheh, Public Health Ontario
Nimitha Paul, Public Health Ontario
Sue Keller-Olaman, Public Health Ontario
Susan Massarella, Toronto Public Health
Jayne Caldwell, , Public Health Ontario
Michael Parkinson, Waterloo Region Crime Prevention Council
Carol Strike, Dalla Lana School of Public Health
Heather Manson, Public Health Ontario

B5.3 Guidelines to Prevent Diversion of Opioids from Canadian Hospitals and Healthcare Facilities

Sarah Jennings, Canadian Society of Hospital Pharmacists
Catherine Lyder, Canadian Society of Hospital Pharmacists


We use cookies to ensure that we give you the best experience possible on our website.

You can change your cookie settings in your web browser at any time. If you continue without changing your settings, we’ll assume that you are happy to receive cookies from our website. Review our Privacy Notice for more information.